The Medical Journal of Australia · 2010 · 37 citations · 9 references
Public HealthInfectious DiseasesPreventive MedicineEpidemiologyImmunizationPublic Health SurveillanceAdult ImmunizationCoverage AssessmentImmunization CoverageImmunization EpidemiologyInfluenza-like Illness SurveillanceVaccinationImmunization Coverage SurveillanceOutcome MeasuresPandemic Influenza SurveillanceSeasonal Influenza VaccinationVaccination Coverage AnalysisVaccination Coverage AssessmentVaccination Coverage SurveysVaccine-preventable Disease Surveillance
OBJECTIVE: To assess pandemic (H1N1) 2009 influenza vaccination coverage in Western Australians, up to 31 January 2010. DESIGN, SETTING AND PARTICIPANTS: Vaccination data for Western Australians aged 10 years and older were obtained from two sources: the WA Pandemic Influenza Vaccination Database (PIVD; which collected reports of pandemic influenza vaccinations from vaccination providers statewide) for the period 30 September 2009 to 31 January 2010, and the WA Health and Wellbeing Surveillance System (HWSS; a continuous population-based telephone survey) for the period 1 December 2009 to 31 January 2010. Data from the PIVD was used to input vaccination coverage estimates for at-risk subpopulations not assessed in the HWSS interviews. MAIN OUTCOME MEASURES: Vaccination coverage of Western Australians aged 10 years and older and of subgroups targeted by the national pandemic (H1N1) 2009 influenza vaccination campaign. RESULTS: A total of 171,789 pandemic influenza vaccinations were reported to the PIVD by 31 January 2010 and 88% of these were administered by 1 December 2009. Based on HWSS data, vaccination coverage of persons aged 10 years and older was 14.5% (95% CI, 12.6%-16.6%) and of persons aged 18 years and older was 15.3% (95% CI, 13.3%-17.6%). Based on PIVD data, coverage in adults ranged from 10.3% in pregnant women to 52.8% in health care workers. CONCLUSIONS: Our estimate of pandemic influenza vaccination coverage in the adult population of WA is comparable to the national estimate of 19%, but it did not reach levels considered sufficient to interrupt community transmission. Future influenza vaccination programs should target groups at increased risk of severe influenza, such as pregnant women.
9
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
Michael E. Greenberg, Michael H. Lai, Günter Härtel et al. · New England Journal of Medicine · 2009 · 494 citations · Full text
Influenza vaccination during pregnancy. Patients' and physicians' attitudes.
Neil S. Silverman, A Greif · PubMed · 2001 · 92 citations